Current Price Status
Stock is Trading within Range
Stock is trading within the fundamental outlook of the company and the industry average performance. Market is currently pricing of annual earning growth better than the industry average.
Company is in Positive Earning
- AHEALTH current price is 9.48% below OneDelta estimated fair value.
The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.
Relative Price Performance
OutperformedAHEALTH past 5-day return perform better than Medical Services industry average return by 3.3%
Below 30-Day AverageCurrent price RM3.48 is below 30-day average RM3.57 by 2.6%
|Return (%)||AHEALTH||Medical Services|
Bank Analyst Price Targets
Revenue & Earning Growth Analysis
Cyclical Revenue Growth
AHEALTH recorded various revenue growth in different quarters with no clear growth direction.
Unstable Profit Growth
AHEALTH has been experiencing substantial ups and downs on profit growth.
Past Quarter Reports
|Quarter Date||Revenue (RM)||(%)||EPS (RM)||(%)|
Volume Trend Analysis
Recent Volume is Decreasing
Decreasing trading volume tends to keep stock price range bound in near term.
Low Volume/Liquidity Stock
Only RM88k worth of stock was traded for this stock past month. Low liquidity stock is danger for price manipulation and more difficult to sell at market price.
AHEALTH recent daily traded volume is 0% lower than past month average.
|Past 30-Day||Past 5-Day|
|1k daily||1k daily|
Price History Chart
Past 30-day Average Price: RM3.57
Stock Fundamental Factors
Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.
Stock Company Profile
APEX HEALTHCARE BHD
Apex Healthcare Bhd. is an investment holding company, which engages in the manufacture and trade of pharmaceutical and consumer healthcare products. It operates through the following business segments: Manufacturing and Marketing; Wholesale and Distribution; and Corporate. The Manufacturing and Marketing segment researches, develops, and sells pharmaceutical products. The Wholesale and Distribution segment offers pharmaceutical and healthcare products. The Corporate segment is comprised of investments in retail pharmacy business, properties, and provision of management services. The company was founded by Tah Peng Kee in 1962 and is headquartered in Melaka, Malaysia.